Anti‐vascular endothelial growth factor for neovascular glaucoma
A Simha, K Aziz, A Braganza… - Cochrane Database …, 2020 - cochranelibrary.com
Background Neovascular glaucoma (NVG) is a potentially blinding, secondary glaucoma. It
is caused by the formation of abnormal new blood vessels, which prevent normal drainage …
is caused by the formation of abnormal new blood vessels, which prevent normal drainage …
Anti‐vascular endothelial growth factor for neovascular glaucoma
T Rittiphairoj, G Roberti… - Cochrane Database of …, 2023 - cochranelibrary.com
Background Neovascular glaucoma (NVG) is a potentially blinding, secondary glaucoma. It
is caused by the formation of abnormal new blood vessels, which prevent normal drainage …
is caused by the formation of abnormal new blood vessels, which prevent normal drainage …
[HTML][HTML] The efficacy and safety of anti-vascular endothelial growth factor combined with Ahmed glaucoma valve implantation in the treatment of neovascular …
CZ He, SJ Lu, ZJ Zeng, JQ Liu, Q Qiu, FL Xue… - Frontiers in …, 2024 - frontiersin.org
Background The intraocular injections of anti-vascular endothelial growth factor (anti-VEGF)
demonstrates significant efficacy in inhibiting the formation of ocular neovascularization in …
demonstrates significant efficacy in inhibiting the formation of ocular neovascularization in …
Does Bevacizumab Improve Outcomes After Ahmed Glaucoma Valve Implantation for Refractory Glaucoma?: A Meta-Analysis
L Tran, J Vo, K Bell, S Perera, J Crowston - Journal of Glaucoma, 2024 - journals.lww.com
Objective: This meta-analysis aims to assess how adjunctive bevacizumab impacts the
surgical outcomes of AGVI compared with AGVI alone in all subtypes of refractory glaucoma …
surgical outcomes of AGVI compared with AGVI alone in all subtypes of refractory glaucoma …
[HTML][HTML] The efficacy of adjunctive mitomycin C and/or anti-VEGF agents on glaucoma tube shunt drainage device surgeries: a systematic review
R Figueiredo, J Barbosa-Breda - Graefe's Archive for Clinical and …, 2024 - Springer
Purpose The effectiveness of mitomycin C (MMC) in trabeculectomy has long been
established. The aim of this review is to evaluate the efficacy and safety of adjunctive agents …
established. The aim of this review is to evaluate the efficacy and safety of adjunctive agents …
Long-term results of Ahmed glaucoma valve implantation with/without intravitreal anti-VEGF injection in neovascular glaucoma patients
V Şahin, Y Ayaz, İ Yücel, EBT Şen - Journal Français d'Ophtalmologie, 2024 - Elsevier
Purpose This study aimed to evaluate the efficacy of Ahmed glaucoma valve (AGV)
implantation with or without anti-VEGF injections in neovascular glaucoma patients …
implantation with or without anti-VEGF injections in neovascular glaucoma patients …
[PDF][PDF] The efficacy of adjunctive mitomycin C and/or anti‑VEGF agents on glaucoma tube shunt drainage device surgeries: a systematic
R Figueiredo, J Barbosa‑Breda - 2024 - lirias.kuleuven.be
Purpose The effectiveness of mitomycin C (MMC) in trabeculectomy has long been
established. The aim of this review is to evaluate the efficacy and safety of adjunctive agents …
established. The aim of this review is to evaluate the efficacy and safety of adjunctive agents …
Evaluación de la efectividad del implante de válvula de AHMED adicionando mitomicina C en pacientes con glaucoma refractario a un año de seguimiento
C Parra Rosas - 2023 - repositorio.unisinucartagena.edu.co
Introducción: La válvula de Ahmed está indicada en el glaucoma refractario a terapia
farmacológica máxima y cirugías filtrantes correctamente realizadas. El éxito se puede ver …
farmacológica máxima y cirugías filtrantes correctamente realizadas. El éxito se puede ver …